The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
Open accessAbstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common human cancer with over 250,000 new cases annually in the US and is second in incidence only to basal cell carcinoma. cSCC typically manifests as a spectrum of progressively advanced malignancies, ranging from a precursor actinic keratosis (AK) to squamous cell carcinoma (SCC) in situ (SCCIS), invasive cSCC, and finally metastatic SCC. In this Review we discuss clinical and molecular parameters used to define this range of cutaneous neoplasia and integrate these with the multiple experimental approaches used to study this disease. Insights gained from modeling cSCCs have suggested innovative therapeutic targets for treating these lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Cited by
Emerging interactions between skin stem cells and their niches
Hsu, Y.-C., Li, L., & Fuchs, E. (2014) · Nature Medicine · doi:10.1038/nm.3643 · Cited by 568
Stratigos, A., Garbe, C., Lebbe, C., Malvehy, J., del Marmol, V., Pehamberger, H., Peris, K., Becker, J. C., Zalaudek, I., Saiag, P., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.110 · Cited by 514
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Hasan, N., Nadaf, A., Imran, M., Jiba, U., Sheikh, A., Almalki, W. H., Almujri, S. S., Mohammed, Y. H., Kesharwani, P., & Ahmad, F. J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01854-3 · Cited by 322
Non Melanoma Skin Cancer Pathogenesis Overview
Didona, D., Paolino, G., Bottoni, U., & Cantisani, C. (2018) · Biomedicines · doi:10.3390/biomedicines6010006 · Cited by 283
An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
Girard, L., Rodriguez-Canales, J., Behrens, C., Thompson, D. M., Botros, I. W., Tang, H., Xie, Y., Rekhtman, N., Travis, W. D., Wistuba, I. I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2900 · Cited by 154
Animal models of skin disease for drug discovery
Avci, P., Sadasivam, M., Gupta, A., De Melo, W. C., Huang, Y.-Y., Yin, R., Chandran, R., Kumar, R., Otufowora, A., Nyame, T., et al. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.761202 · Cited by 130
“Injection of nude mice with Notch1-deficient primary keratinocytes expressing activated Ras treated with a Notch signaling inhibitor results in the formation of poorly differentiated and invasive SCC [13].”
BackgroundInfluentialMelanin Transfer and Fate within Keratinocytes in Human Skin Pigmentation
Benito-Martínez, S., Salavessa, L., Raposo, G., Marks, M. S., & Delevoye, C. (2021) · Integrative and Comparative Biology · doi:10.1093/icb/icab094 · Cited by 78
Nissinen, L., Farshchian, M., Riihilä, P., & Kähäri, V.-M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2457-z · Cited by 80
“…molecules involved in the progression of cSCC include Signal transducer and activator of transcription 3 (STAT3), p63-fibroblast growth factor receptor-2 (p63- FGFR2), phosphatidyl inositol 3-kinase (PI3K/AKT), Wnt/ β-catenin, and TGF-β signaling (Lim and South 2014; Ratushny et al. 2012).”
BackgroundInfluentialNetwork Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXR
Bhaduri, A., Ungewickell, A., Boxer, L. D., Lopez-Pajares, V., Zarnegar, B. J., & Khavari, P. A. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.10.023 · Cited by 60
“We chose this filter for disease relevance because cSCC is a disease characterized by a loss of differentiation (Kwa et al., 1992; Ratushny et al., 2012; Rowe et al., 1992) and candidates highlighted by this filter were more likely to also be of interest in the study of cSCC or other…”
MethodAzazmeh, N., Assouline, B., Winter, E., Ruppo, S., Nevo, Y., Maly, A., Meir, K., Witkiewicz, A. K., Cohen, J., Rizou, S. V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16475-3 · Cited by 57
Boone, M. A. L. M., Norrenberg, S., Jemec, G. B. E., & Del Marmol, V. (2013) · Experimental Dermatology · doi:10.1111/exd.12074 · Cited by 55
A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis
Reinhold, U. (2017) · Future Oncology · doi:10.2217/fon-2017-0247 · Cited by 46
Fischer, B., Metzger, M., Richardson, R., Knyphausen, P., Ramezani, T., Franzen, R., Schmelzer, E., Bloch, W., Carney, T. J., & Hammerschmidt, M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004048 · Cited by 40
“Such a proliferation-stimulating role seems in contrast to the known functions of Notch and p53 as tumour suppressors [71,72].”
BackgroundBennet, D., & Kim, S. (2015) · The Analyst · doi:10.1039/c5an00979k · Cited by 17
Role of Dendritic Epidermal T Cells in Cutaneous Carcinoma
Xiang, J., Qiu, M., & Zhang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01266 · Cited by 11
Metadata
- Authors
- Ratushny, V., Gober, M. D., Hick, R., Ridky, T. W., & Seykora, J. T.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-02-01
- Volume
- 122
- Issue
- 2
- Pages
- 464-472
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2084077080
- Cited by
- 545
- References
- 102
- FWCI
- 29.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.